Treace Medical Concepts, Inc.
NASDAQ:TMCI · NASDAQ Global Select
+$0.08 today
Vol 1.39M · Avg 0.73M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-27.00%
Period High
$7.70
Period Low
$1.20
Latest
$4.19
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Enhabit, Inc.
EHAB
$706.91M
CeriBell, Inc.
NASDAQ:CBLL
$673.67M
Surmodics, Inc.
SRDX
$614.51M
Bioventus Inc.
NASDAQ:BVS
$592.46M
The Oncology Institute, Inc.
NASDAQ:TOI
$517.91M
OrthoPediatrics Corp.
NASDAQ:KIDS
$472.99M
Evolus, Inc.
NASDAQ:EOLS
$436.08M
Standard BioTools Inc.
NASDAQ:LAB
$325.96M
Semler Scientific, Inc.
SMLR
$310.75M
RxSight, Inc.
NASDAQ:RXST
$191.87M
What is the latest TMCI filing?
The latest filing shown is 4/A dated Jun 12, 2026.
How many recent filings does TMCI have?
Intrinsic Alpha currently shows 20 recent filings for TMCI.
Explore More
Continue the stock analysis
Jump to another research area for this company.